Combination Chemotherapy in Treating Patients With Hodgkin's Disease and HIV Infection

NCT00003262 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: bleomycin sulfate
BIOLOGICAL: filgrastim
DRUG: Stanford V regimen
DRUG: doxorubicin hydrochloride
DRUG: epirubicin hydrochloride
DRUG: etoposide
DRUG: mechlorethamine hydrochloride
DRUG: prednisone
DRUG: vinblastine sulfate
DRUG: vincristine sulfate

Sponsor

Centro di Riferimento Oncologico - Aviano